Baolingbao Biology Co.,Ltd. (SHE:002286)

China flag China · Delayed Price · Currency is CNY
10.12
+0.09 (0.90%)
Jan 23, 2026, 3:04 PM CST
32.29%
Market Cap3.82B
Revenue (ttm)2.69B
Net Income (ttm)144.09M
Shares Out380.57M
EPS (ttm)0.39
PE Ratio25.68
Forward PE21.57
Dividend0.12 (1.21%)
Ex-Dividend DateJul 3, 2025
Volume18,603,619
Average Volume14,536,717
Open9.58
Previous Close10.03
Day's Range9.58 - 10.18
52-Week Range6.45 - 13.40
Beta0.33
RSI69.23
Earnings DateApr 25, 2026

About Baolingbao Biology

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, incl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 1,395
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002286
Full Company Profile

Financial Performance

In 2024, Baolingbao Biology's revenue was 2.40 billion, a decrease of -4.84% compared to the previous year's 2.52 billion. Earnings were 111.16 million, an increase of 105.97%.

Financial Statements